Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279853

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279853

Global Submucosal Injections Market Size study & Forecast, by Type of Agent, By Application, By End User, and Regional Analysis, 2023-2030

PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Submucosal Injections Market is valued at approximately USD 1.23 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2023-2030. Submucosal injection is a medical technique that involves injecting drugs or other therapeutic substances into a tissue or organ's submucosal layer. The submucosal layer is the layer of tissue that lies just below the mucous membrane, which lines the inner surface of various organs, such as the gastrointestinal tract, respiratory tract, and urinary tract. Submucosal injections are commonly used in medical and surgical procedures for diagnostic, therapeutic, or palliative purposes. The rising incidences of cancer, the surge in the number of endoscopic mucosal resection procedures, increasing favorable reimbursement policies, and the development of the healthcare sector are the key driving factors for market growth across the globe.

In addition, the rising preference towards minimally invasive procedures is playing a vital role in stipulating market growth across the globe. Submucosal injections are minimally invasive procedures that offer advantages such as reduced postoperative complications, faster recovery, and shorter hospital stays. According to Statista, the worldwide revenue for minimally invasive surgery reached around USD 20.5 billion in 2019. This amount is also anticipated to increase and is expected to reach about USD 44.04 billion by 2030. As the trend towards minimally invasive procedures continues to gain traction, the demand for submucosal injections as part of these procedures is expected to increase during the estimated period. Moreover, the rising adoption of advanced technology in healthcare, as well as the rising focus on early diagnosis and intervention present various lucrative opportunities over the forecasting years. However, the unavailability of skilled healthcare professionals and the presence of alternative treatment options are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Submucosal Injections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising endoscopic mucosal resection procedures, and the presence of well-established healthcare facilities. Whereas, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as favorable government initiatives, increasing healthcare expenditure, and Increased application of submucosal injections in the market space.

Major market players included in this report are:

  • Bio Space Inc.
  • Cosmo Pharmaceuticals N.V.
  • FUJIFILM Medical Systems
  • Medtronic Plc.
  • Zeon Medical Inc.
  • Boston Scientific Corporation
  • Aries Pharmaceuticals
  • Sumitomo Bakelite Company Limited
  • ERBE Elektromedizin GmbH
  • Ovesco Endoscopy AG

Recent Developments in the Market:

  • In September 2022, Olympus announced that the USA distribution of EndoClot Submucosal Injection Solution and EndoClot Polysaccharide Hemostatic Spray, which is designed by Endoclot Plus Inc.

Global Submucosal Injections Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Type of Agent, Application, End User, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type of Agent:

  • Normal saline
  • Dextrose water
  • Hydroxyethyl starch
  • Hydroxypropyl methylcellulose
  • Succinylated gelatin
  • Hyaluronic acid
  • Others

By Application:

  • Colorectal Cancer
  • Gastric Cancer
  • Esophageal Cancer

By End User:

  • Hospitals
  • Surgical Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Submucosal Injections Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Submucosal Injections Market, by Type of Agent, 2020-2030 (USD Billion)
    • 1.2.3. Submucosal Injections Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Submucosal Injections Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Submucosal Injections Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Submucosal Injections Market Dynamics

  • 3.1. Submucosal Injections Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Surge in the number of endoscopic mucosal resection procedures
      • 3.1.1.2. Rising preference towards minimally invasive procedures
    • 3.1.2. Market Challenges
      • 3.1.2.1. Unavailability of skilled healthcare professionals
      • 3.1.2.2. Presence of alternative treatment options
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing adoption of advanced technology in healthcare
      • 3.1.3.2. Rising focus on early diagnosis and Intervention

Chapter 4. Global Submucosal Injections Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Submucosal Injections Market, by Type of Agent

  • 5.1. Market Snapshot
  • 5.2. Global Submucosal Injections Market by Type of Agent, Performance - Potential Analysis
  • 5.3. Global Submucosal Injections Market Estimates & Forecasts by Type of Agent 2020-2030 (USD Billion)
  • 5.4. Submucosal Injections Market, Sub Segment Analysis
    • 5.4.1. Normal saline
    • 5.4.2. Dextrose water
    • 5.4.3. Hydroxyethyl starch
    • 5.4.4. Hydroxypropyl methylcellulose
    • 5.4.5. Succinylated gelatin
    • 5.4.6. Hyaluronic acid
    • 5.4.7. Others

Chapter 6. Global Submucosal Injections Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Submucosal Injections Market by Application, Performance - Potential Analysis
  • 6.3. Global Submucosal Injections Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Submucosal Injections Market, Sub Segment Analysis
    • 6.4.1. Colorectal Cancer
    • 6.4.2. Gastric Cancer
    • 6.4.3. Esophageal Cancer

Chapter 7. Global Submucosal Injections Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global Submucosal Injections Market by End User, Performance - Potential Analysis
  • 7.3. Global Submucosal Injections Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 7.4. Submucosal Injections Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Surgical Centers
    • 7.4.3. Others

Chapter 8. Global Submucosal Injections Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Submucosal Injections Market, Regional Market Snapshot
  • 8.4. North America Submucosal Injections Market
    • 8.4.1. U.S. Submucosal Injections Market
      • 8.4.1.1. Type of Agent breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Submucosal Injections Market
  • 8.5. Europe Submucosal Injections Market Snapshot
    • 8.5.1. U.K. Submucosal Injections Market
    • 8.5.2. Germany Submucosal Injections Market
    • 8.5.3. France Submucosal Injections Market
    • 8.5.4. Spain Submucosal Injections Market
    • 8.5.5. Italy Submucosal Injections Market
    • 8.5.6. Rest of Europe Submucosal Injections Market
  • 8.6. Asia-Pacific Submucosal Injections Market Snapshot
    • 8.6.1. China Submucosal Injections Market
    • 8.6.2. India Submucosal Injections Market
    • 8.6.3. Japan Submucosal Injections Market
    • 8.6.4. Australia Submucosal Injections Market
    • 8.6.5. South Korea Submucosal Injections Market
    • 8.6.6. Rest of Asia Pacific Submucosal Injections Market
  • 8.7. Latin America Submucosal Injections Market Snapshot
    • 8.7.1. Brazil Submucosal Injections Market
    • 8.7.2. Mexico Submucosal Injections Market
  • 8.8. Middle East & Africa Submucosal Injections Market
    • 8.8.1. Saudi Arabia Submucosal Injections Market
    • 8.8.2. South Africa Submucosal Injections Market
    • 8.8.3. Rest of Middle East & Africa Submucosal Injections Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Bio Space Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Cosmo Pharmaceuticals N.V.
    • 9.3.3. FUJIFILM Medical Systems
    • 9.3.4. Medtronic Plc.
    • 9.3.5. Zeon Medical Inc.
    • 9.3.6. Boston Scientific Corporation
    • 9.3.7. Aries Pharmaceuticals
    • 9.3.8. Sumitomo Bakelite Company Limited
    • 9.3.9. ERBE Elektromedizin GmbH
    • 9.3.10. Ovesco Endoscopy AG.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Submucosal Injections Market, report scope
  • TABLE 2. Global Submucosal Injections Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Submucosal Injections Market estimates & forecasts by Type of Agent 2020-2030 (USD Billion)
  • TABLE 4. Global Submucosal Injections Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Submucosal Injections Market estimates & forecasts by End User 2020-2030 (USD Billion)
  • TABLE 6. Global Submucosal Injections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Submucosal Injections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Submucosal Injections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Submucosal Injections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Submucosal Injections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Submucosal Injections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Submucosal Injections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Submucosal Injections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Submucosal Injections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Submucosal Injections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Submucosal Injections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Submucosal Injections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Submucosal Injections Market
  • TABLE 71. List of primary sources, used in the study of global Submucosal Injections Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Submucosal Injections Market, research methodology
  • FIG 2. Global Submucosal Injections Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Submucosal Injections Market, key trends 2022
  • FIG 5. Global Submucosal Injections Market, growth prospects 2023-2030
  • FIG 6. Global Submucosal Injections Market, porters 5 force model
  • FIG 7. Global Submucosal Injections Market, pest analysis
  • FIG 8. Global Submucosal Injections Market, value chain analysis
  • FIG 9. Global Submucosal Injections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Submucosal Injections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Submucosal Injections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Submucosal Injections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Submucosal Injections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Submucosal Injections Market, regional snapshot 2020 & 2030
  • FIG 15. North America Submucosal Injections Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Submucosal Injections Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Submucosal Injections Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Submucosal Injections Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Submucosal Injections Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!